Catalio Capital Management, LP Regeneron Pharmaceuticals, Inc. Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 12,261 shares of REGN stock, worth $7.29 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
12,261Holding current value
$7.29 Million% of portfolio
1.89%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.59 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.36 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.85 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.37 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $63.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...